eLearning

Drug Development Through the Prism of Biomarkers: Current State and Future Outlook

Posted By Matt Baughman
Found In Microsite: AAPS Newsmagazine
Table of Contents Meetings April 2023 By Mohamed Hassanein (Pfizer), Xiazi Qiu (Novartis), Jianing Zeng (Bristol Myers Squibb), and Amanda Hays (BioAgilytix)   Biomarkers in Drug Development Biomarkers are objective and measurable indicators of biological ...

eChalk Talk: Cytokine Analysis in Non-Clinical Studies: Thoughts on Ability to Relate Cytokine

Posted By Matt Baughman
Found In Microsite: AAPS Newsmagazine
AAPS eLearning September 12, 2022 By John Farmer, Ph.D.  Register to join Dr. Farmer’s eChalk Talk on Wednesday, September 28, 2022! Cytokine multiplex analysis utilizing the Luminex platform measuring up to 80 analytes has become routine in nonclinical ...

China’s Latest Approach to Drug Development and Approvals

Posted By Matt Baughman
Found In Microsite: AAPS Newsmagazine
Table of Contents AAPS eLearning March 2021 By Cathy Yarbrough Over the past decade, China has overhauled its regulations governing drug development and approval. In addition to encouraging medical innovation, China’s regulatory reforms are designed ...

Leveraging Modern-Day A.I. for Pandemic Response

Posted By Matt Baughman
Found In Microsite: AAPS Newsmagazine
Drug researchers are turning to computational chemistry to more quickly learn about potential drug targets as they develop treatments for COVID-19 and other pandemics By David Pittman It can take up to a decade for a drug to move from the discovery ...

Advances in Bioavailability Enhancing Technologies for Poorly Soluble Molecules: in vitro and in viv

Posted By Matt Baughman
Found In Microsite: AAPS Newsmagazine
by Cathy Yarbrough Global drug pipelines contain an “increasing number of low solubility and poor permeability compounds,” David Lyon, Ph.D., Research at Lonza, said when introducing the AAPS webinar, Advances in bioavailability enhancing technologies ...